Tourmaline Bio Inc. Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
-28M
-42M
0M
6M
9M
0M
4M
0M
157M
0M
-0 %
0M
0M
0M
141M
132M
8M
-28M
-6M
-20M
0M
0M
12M
1M
-5M
5M
20M
0M
-0 %
0M
0M
0M
8M
8M
0M
-12M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
11M
2M
-1M
0M
0M
2M
-88M
0M
156M
0M
0 %
0M
0M
0M
141M
79M
67M
12M
-26M
-6M
1M
5M
0M
-2M
92M
1M
-92M
0M
-0 %
0M
0M
0M
67M
-25M
87M
-26M
0M
-16M
0M
0M
0M
0M
0M
0M
0M
0M
-0 %
0M
0M
0M
87M
0M
0M
0M
0M
-8M
0M
0M
0M
0M
0M
0M
0M
0M
0 %
0M
0M
0M
0M
0M
8M
0M
41M
36M
-2M
-8M
0M
2M
-52M
2M
20M
0M
0 %
0M
0M
0M
8M
8M
18M
38M
-46M
-19M
2M
8M
0M
-1M
52M
0M
-20M
0M
0 %
0M
0M
0M
18M
-14M
14M
-44M